Works matching AU Tamiya, Akihiro

Results: 59
    1
    2

    Duration of Twice-Daily Thoracic Radiotherapy and Time From the Start of Any Treatment to the End of Chest Irradiation as Significant Predictors of Outcomes in Limited-Disease Small-Cell Lung Cancer.

    Published in:
    2017
    By:
    • Masahiro Morimoto;
    • Kyoichi Okishio;
    • Masanori Akira;
    • Naoki Omachi;
    • Akihiro Tamiya;
    • Kazuhiro Asami;
    • Tomoya Kawaguchi;
    • Shinji Atagi;
    • Morimoto, Masahiro;
    • Okishio, Kyoichi;
    • Akira, Masanori;
    • Omachi, Naoki;
    • Tamiya, Akihiro;
    • Asami, Kazuhiro;
    • Kawaguchi, Tomoya;
    • Atagi, Shinji
    Publication type:
    journal article
    3
    4
    5
    6
    7

    Sequencing strategies with ramucirumab and docetaxel following prior treatments for advanced non-small cell lung cancer: a multicenter retrospective cohort study.

    Published in:
    European Journal of Clinical Pharmacology, 2023, v. 79, n. 4, p. 503, doi. 10.1007/s00228-023-03452-0
    By:
    • Tanizaki, Satoshi;
    • Matsumoto, Kinnosuke;
    • Tamiya, Akihiro;
    • Taniguchi, Yoshihiko;
    • Matsuda, Yoshinobu;
    • Uchida, Junji;
    • Ueno, Kiyonobu;
    • Kawachi, Hayato;
    • Tamiya, Motohiro;
    • Yanase, Takafumi;
    • Suzuki, Hidekazu;
    • Okishio, Kyoichi
    Publication type:
    Article
    8

    Randomized Phase H Trial of Amrubicin Plus Irinotecan Versus Cisplatin Plus lrinotecan in Chemo-naïve Patients With Extensive-Disease Small-Cell Lung Cancer: Results of the Japan Multinational Trial Organization (JMTO) LC 08-01.

    Published in:
    Clinical Lung Cancer, 2025, v. 26, n. 1, p. 1, doi. 10.1016/j.cllc.2024.09.004
    By:
    • Hiroshige Yoshioka;
    • Tadashi Ishida;
    • Shinji Atagi;
    • Akihiro Tamiya;
    • Takashi Nishimura;
    • Yasuo Iwamoto;
    • Masashi Kanehara;
    • Young Hak Kim;
    • Yohei Korogi;
    • Keisuke Tomii;
    • Nobuyuki Katakami;
    • Kiyoshi Komuta;
    • Masanori Nishikawa;
    • Akihiko Gemma;
    • Kenichi Yamaki;
    • Masaaki Kawahara;
    • Chisato Miyakoshi;
    • Tadashi Mio
    Publication type:
    Article
    9
    10
    11

    Association Between Early Immune-related Adverse Events and Clinical Outcomes in Patients With Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors.

    Published in:
    2020
    By:
    • Hosoya, Kazutaka;
    • Fujimoto, Daichi;
    • Morimoto, Takeshi;
    • Kumagai, Toru;
    • Tamiya, Akihiro;
    • Taniguchi, Yoshihiko;
    • Yokoyama, Toshihide;
    • Ishida, Tadashi;
    • Hirano, Katsuya;
    • Matsumoto, Hirotaka;
    • Kominami, Ryota;
    • Tomii, Keisuke;
    • Suzuki, Hidekazu;
    • Hirashima, Tomonori;
    • Uchida, Junji;
    • Morita, Mitsunori;
    • Kanazu, Masaki;
    • Sawa, Nobuhiko;
    • Makio, Takeshi;
    • Hara, Satoshi
    Publication type:
    journal article
    12
    13
    14
    15
    16

    Risk Stratification According to Baseline and Early Change in Neutrophil-to-Lymphocyte Ratio in Advanced Non-Small Cell Lung Cancer Treated with Chemoimmunotherapy: A Multicenter Real-World Study.

    Published in:
    Targeted Oncology, 2024, v. 19, n. 5, p. 757, doi. 10.1007/s11523-024-01084-7
    By:
    • Matsumoto, Kinnosuke;
    • Yamamoto, Yuji;
    • Shiroyama, Takayuki;
    • Kuge, Tomoki;
    • Mori, Masahide;
    • Tamiya, Motohiro;
    • Kinehara, Yuhei;
    • Tamiya, Akihiro;
    • Suzuki, Hidekazu;
    • Tobita, Satoshi;
    • Ueno, Kiyonobu;
    • Niki, Toshie;
    • Nagatomo, Izumi;
    • Takeda, Yoshito;
    • Kumanogoh, Atsushi
    Publication type:
    Article
    17

    Real-world outcomes of nivolumab plus ipilimumab and pembrolizumab with platinum-based chemotherapy in advanced non-small cell lung cancer: a multicenter retrospective comparative study.

    Published in:
    Cancer Immunology, Immunotherapy, 2024, v. 73, n. 1, p. 1, doi. 10.1007/s00262-023-03583-4
    By:
    • Matsumoto, Kinnosuke;
    • Shiroyama, Takayuki;
    • Tamiya, Motohiro;
    • Minami, Toshiyuki;
    • Kinehara, Yuhei;
    • Tamiya, Akihiro;
    • Suga, Yasuhiko;
    • Kuge, Tomoki;
    • Mori, Masahide;
    • Suzuki, Hidekazu;
    • Tobita, Satoshi;
    • Ueno, Kiyonobu;
    • Namba, Yoshinobu;
    • Tetsumoto, Satoshi;
    • Niki, Toshie;
    • Morimura, Osamu;
    • Osa, Akio;
    • Nishino, Kazumi;
    • Nagatomo, Izumi;
    • Takeda, Yoshito
    Publication type:
    Article
    18
    19

    Baseline genetic abnormalities and effectiveness of osimertinib treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC based on performance status.

    Published in:
    BMC Pulmonary Medicine, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12890-024-03212-5
    By:
    • Taniguchi, Yoshihiko;
    • Tamiya, Akihiro;
    • Osuga, Mitsuo;
    • Harada, Daijiro;
    • Isa, Shun-ichi;
    • Nakamura, Keiichi;
    • Mizumori, Yasuyuki;
    • Shinohara, Tsutomu;
    • Yanai, Hidetoshi;
    • Nakatomi, Katsumi;
    • Oki, Masahide;
    • Mori, Masahide;
    • Kuwako, Tomohito;
    • Yamazaki, Koji;
    • Tamura, Atsuhisa;
    • Ando, Masahiko;
    • Koh, Yasuhiro
    Publication type:
    Article
    20
    21
    22
    23
    24

    The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV.

    Published in:
    International Journal of Clinical Oncology, 2019, v. 24, n. 7, p. 731, doi. 10.1007/s10147-019-01431-z
    By:
    • Akamatsu, Hiroaki;
    • Ninomiya, Kiichiro;
    • Kenmotsu, Hirotsugu;
    • Morise, Masahiro;
    • Daga, Haruko;
    • Goto, Yasushi;
    • Kozuki, Toshiyuki;
    • Miura, Satoru;
    • Sasaki, Takaaki;
    • Tamiya, Akihiro;
    • Teraoka, Shunsuke;
    • Tsubata, Yukari;
    • Yoshioka, Hiroshige;
    • Hattori, Yoshihiro;
    • Imamura, Chiyo K.;
    • Katsuya, Yuki;
    • Matsui, Reiko;
    • Minegishi, Yuji;
    • Mizugaki, Hidenori;
    • Nosaki, Kaname
    Publication type:
    Article
    25

    Prognostic Awareness and Discussions of Incurability in Patients with Pretreated Non-Small Cell Lung Cancer and Caregivers: A Prospective Cohort Study.

    Published in:
    Oncologist, 2022, v. 27, n. 11, p. 982, doi. 10.1093/oncolo/oyac178
    By:
    • Hasegawa, Takaaki;
    • Okuyama, Toru;
    • Uemura, Takehiro;
    • Matsuda, Yoshinobu;
    • Otani, Hiroyuki;
    • Shimizu, Junichi;
    • Horio, Yoshitsugu;
    • Watanabe, Naohiro;
    • Yamaguchi, Teppei;
    • Fukuda, Satoshi;
    • Oguri, Tetsuya;
    • Maeno, Ken;
    • Tamiya, Akihiro;
    • Nosaki, Kaname;
    • Fukumitsu, Kensuke;
    • Akechi, Tatsuo
    Publication type:
    Article
    26

    Circulating Tumour DNA in Patients With EGFR‐Mutated Non‐Small‐Cell Lung Cancer and Early Disease Progression After First‐Line Osimertinib Treatment: The ELUCIDATOR Multicentre Prospective Observational Study.

    Published in:
    Cancer Medicine, 2025, v. 14, n. 7, p. 1, doi. 10.1002/cam4.70861
    By:
    • Tamiya, Akihiro;
    • Mizumori, Yasuyuki;
    • Osuga, Mitsuo;
    • Isa, Shun‐ichi;
    • Taniguchi, Yoshihiko;
    • Nakamura, Keiichi;
    • Harada, Daijiro;
    • Shinohara, Tsutomu;
    • Yanai, Hidetoshi;
    • Nakatomi, Katsumi;
    • Oki, Masahide;
    • Mori, Masahide;
    • Kuwako, Tomohito;
    • Yamazaki, Koji;
    • Tamura, Atsuhisa;
    • Ando, Masahiko;
    • Koh, Yasuhiro
    Publication type:
    Article
    27

    Impact of somatic mutations on prognosis in resected non‐small‐cell lung cancer: The Japan Molecular Epidemiology for lung cancer study.

    Published in:
    Cancer Medicine, 2020, v. 9, n. 7, p. 2343, doi. 10.1002/cam4.2897
    By:
    • Tamiya, Akihiro;
    • Koh, Yasuhiro;
    • Isa, Shun‐ichi;
    • Kubo, Akihito;
    • Ando, Masahiko;
    • Saka, Hideo;
    • Yoshimoto, Naoki;
    • Takeo, Sadanori;
    • Adachi, Hirofumi;
    • Tagawa, Tsutomu;
    • Kawashima, Osamu;
    • Yamashita, Motohiro;
    • Kataoka, Kazuhiko;
    • Takenoyama, Mitsuhiro;
    • Takeuchi, Yukiyasu;
    • Watanabe, Katsuya;
    • Matsumura, Akihide;
    • Kawaguchi, Tomoya
    Publication type:
    Article
    28
    29
    30

    Actual status of adjuvant chemotherapy for non-small-cell lung cancer at one Japanese cancer center: the need for increased cooperation between medical oncologists and surgeons.

    Published in:
    Medical Oncology, 2010, v. 27, n. 3, p. 932, doi. 10.1007/s12032-009-9309-6
    By:
    • Shukuya, Takehito;
    • Takahashi, Toshiaki;
    • Tamiya, Akihiro;
    • Ono, Akira;
    • Igawa, Satoshi;
    • Nakamura, Yukiko;
    • Tsuya, Asuka;
    • Murakami, Haruyasu;
    • Endo, Masahiro;
    • Ohde, Yasuhisa;
    • Nakagawa, Kazuo;
    • Okumura, Takehiro;
    • Kondo, Haruhiko;
    • Yamamoto, Nobuyuki
    Publication type:
    Article
    31
    32

    Evaluation of the Safety and Compliance of 3-Week Cycles of Vinorelbine on Days 1 and 8 and Cisplatin on Day 1 as Adjuvant Chemotherapy in Japanese Patients with Completely Resected Pathological Stage IB to IIIA Non-small Cell Lung Cancer: A ...

    Published in:
    Japanese Journal of Clinical Oncology, 2009, v. 39, n. 3, p. 158
    By:
    • Shukuya, Takehito;
    • Takahashi, Toshiaki;
    • Tamiya, Akihiro;
    • Ono, Akira;
    • Igawa, Satoshi;
    • Tsuya, Asuka;
    • Nakamura, Yukiko;
    • Murakami, Haruyasu;
    • Naito, Tateaki;
    • Kaira, Kyoichi;
    • Endo, Masahiro;
    • Yamamoto, Nobuyuki
    Publication type:
    Article
    33
    34
    35
    36
    37
    38

    Clinical factors associated with shorter durable response, and patterns of acquired resistance to first-line pembrolizumab monotherapy in PD-L1-positive non-small-cell lung cancer patients: a retrospective multicenter study.

    Published in:
    2021
    By:
    • Hosoya, Kazutaka;
    • Fujimoto, Daichi;
    • Morimoto, Takeshi;
    • Kumagai, Toru;
    • Tamiya, Akihiro;
    • Taniguchi, Yoshihiko;
    • Yokoyama, Toshihide;
    • Ishida, Tadashi;
    • Matsumoto, Hirotaka;
    • Hirano, Katsuya;
    • Kominami, Ryota;
    • Tomii, Keisuke;
    • Suzuki, Hidekazu;
    • Hirashima, Tomonori;
    • Tanaka, Satoshi;
    • Uchida, Junji;
    • Morita, Mitsunori;
    • Kanazu, Masaki;
    • Mori, Masahide;
    • Nagata, Kenji
    Publication type:
    journal article
    39
    40
    41

    Stage-specific efficacy of osimertinib in treatment-naïve EGFR-mutant non-small cell lung cancer according to baseline genetic alterations in circulating tumor DNA.

    Published in:
    Investigational New Drugs, 2025, v. 43, n. 1, p. 101, doi. 10.1007/s10637-024-01500-9
    By:
    • Taniguchi, Yoshihiko;
    • Tamiya, Akihiro;
    • Osuga, Mitsuo;
    • Isa, Shun-ichi;
    • Nakamura, Keiichi;
    • Mizumori, Yasuyuki;
    • Shinohara, Tsutomu;
    • Yanai, Hidetoshi;
    • Nakatomi, Katsumi;
    • Oki, Masahide;
    • Mori, Masahide;
    • Kuwako, Tomohito;
    • Yamazaki, Koji;
    • Shimada, Masahiro;
    • Ando, Masahiko;
    • Koh, Yasuhiro
    Publication type:
    Article
    42
    43

    Classification and regression tree for estimating predictive markers to detect T790M mutations after acquired resistance to first line EGFR-TKI: HOPE-002.

    Published in:
    Investigational New Drugs, 2022, v. 40, n. 2, p. 361, doi. 10.1007/s10637-021-01203-5
    By:
    • Tamiya, Motohiro;
    • Fujikawa, Kei;
    • Suzuki, Hidekazu;
    • Yokoyama, Toshihide;
    • Uenami, Takeshi;
    • Tamiya, Akihiro;
    • Sato, Yuki;
    • Saito, Go;
    • Uchida, Junji;
    • Morita, Mitsunori;
    • Hirashima, Tomonori;
    • Fukuda, Yasushi;
    • Kanazu, Masaki;
    • Hosoya, Kazutaka;
    • Suzuki, Takuji;
    • Ueno, Kiyonobu;
    • Fujimoto, Daichi;
    • Kumagai, Toru;
    • Teramukai, Satoshi
    Publication type:
    Article
    44

    Phase 2 study of bevacizumab plus carboplatin/nab-paclitaxel followed by bevacizumab plus nab‐paclitaxel for non‐squamous non‐small cell lung cancer with malignant pleural effusion.

    Published in:
    Investigational New Drugs, 2021, v. 39, n. 4, p. 1106, doi. 10.1007/s10637-021-01076-8
    By:
    • Tamiya, Motohiro;
    • Tamiya, Akihiro;
    • Suzuki, Hidekazu;
    • Taniguchi, Yoshihiko;
    • Katayama, Kanako;
    • Minomo, Shojiro;
    • Nakao, Keiko;
    • Takeuchi, Naoko;
    • Matsuda, Yoshinobu;
    • Naito, Yujiro;
    • Shiroyama, Takayuki;
    • Okamoto, Norio;
    • Okishio, Kyoichi;
    • Kumagai, Toru;
    • Atagi, Shinji;
    • Imamura, Fumio;
    • Hirashima, Tomonori
    Publication type:
    Article
    45

    Durvalumab for patients with unresectable stage III non-small cell lung cancer and grade 1 radiation pneumonitis following concurrent chemoradiotherapy: a multicenter prospective cohort study.

    Published in:
    Investigational New Drugs, 2021, v. 39, n. 3, p. 853, doi. 10.1007/s10637-020-01060-8
    By:
    • Sugimoto, Takeya;
    • Fujimoto, Daichi;
    • Sato, Yuki;
    • Tamiya, Motohiro;
    • Yokoi, Takashi;
    • Tamiya, Akihiro;
    • Iwasawa, Shunichiro;
    • Hata, Akito;
    • Uchida, Junji;
    • Fukuda, Yasushi;
    • Hara, Satoshi;
    • Kanazu, Masaki;
    • Hirano, Katsuya;
    • Kokubo, Masaki;
    • Yamamoto, Nobuyuki
    Publication type:
    Article
    46

    Association between metastatic sites and first-line pembrolizumab treatment outcome for advanced non–small cell lung cancer with high PD-L1 expression: a retrospective multicenter cohort study.

    Published in:
    Investigational New Drugs, 2020, v. 38, n. 1, p. 211, doi. 10.1007/s10637-019-00882-5
    By:
    • Kawachi, Hayato;
    • Tamiya, Motohiro;
    • Tamiya, Akihiro;
    • Ishii, Seigo;
    • Hirano, Katsuya;
    • Matsumoto, Hirotaka;
    • Fukuda, Yasushi;
    • Yokoyama, Toshihide;
    • Kominami, Ryota;
    • Fujimoto, Daichi;
    • Hosoya, Kazutaka;
    • Suzuki, Hidekazu;
    • Hirashima, Tomonori;
    • Kanazu, Masaki;
    • Sawa, Nobuhiko;
    • Uchida, Junji;
    • Morita, Mitsunori;
    • Makio, Takeshi;
    • Hara, Satoshi;
    • Kumagai, Toru
    Publication type:
    Article
    47

    Efficacy and safety of pembrolizumab as first-line therapy in advanced non-small cell lung cancer with at least 50% PD-L1 positivity: a multicenter retrospective cohort study (HOPE-001).

    Published in:
    Investigational New Drugs, 2019, v. 37, n. 6, p. 1266, doi. 10.1007/s10637-019-00843-y
    By:
    • Tamiya, Motohiro;
    • Tamiya, Akihiro;
    • Hosoya, Kazutaka;
    • Taniguchi, Yoshihiko;
    • Yokoyama, Toshihide;
    • Fukuda, Yasushi;
    • Hirano, Katsuya;
    • Matsumoto, Hirotaka;
    • Kominami, Ryota;
    • Suzuki, Hidekazu;
    • Hirashima, Tomonori;
    • Uchida, Junji;
    • Morita, Mitsunori;
    • Kanazu, Masaki;
    • Sawa, Nobuhiko;
    • Kinoshita, Yoshinori;
    • Hara, Satoshi;
    • Kumagai, Toru;
    • Fujimoto, Daichi
    Publication type:
    Article
    48
    49

    Phase1 study of cisplatin plus pemetrexed with erlotinib and bevacizumab for chemotherapy-naïve advanced non-squamous non-small cell lung cancer with EGFR mutations.

    Published in:
    Investigational New Drugs, 2018, v. 36, n. 4, p. 608, doi. 10.1007/s10637-017-0527-z
    By:
    • Tamiya, Motohiro;
    • Tamiya, Akihiro;
    • Shiroyama, Takayuki;
    • Takeoka, Sawa;
    • Naito, Yujiro;
    • Omachi, Naoki;
    • Kimura, Yohei;
    • Morishita, Naoko;
    • Suzuki, Hidekazu;
    • Okamoto, Norio;
    • Okishio, Kyoichi;
    • Kawaguchi, Tomoya;
    • Atagi, Shinji;
    • Hirashima, Tomonori
    Publication type:
    Article
    50